Johns Hopkins Diabetes Guide
Antimicrobials with Special Precautions in Diabetes
Antimicrobials with Special Precautions in Diabetes is a topic covered in the Johns Hopkins Diabetes Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
DEFINITION
- Certain antibiotics may produce undesired changes in glycemic control when used in persons with diabetes.
- No apparent interactions are described between antibiotics and insulins.
- Serum concentrations of hypoglycemic agents may change due to inhibition or induction of oxidative metabolism (i.e. cytochrome P450 system) including: meglitinides (repaglinide, nateglinide), sulfonylureas (glyburide, glimepiride, glipizide), and glitizones (pioglitazone, rosiglitazone).
- Specific cytochrome P450 substrates: repaglinide (2C8, 3A4); nateglinide (2C9>3A4); glyburide and glipizide (2C9); pioglitazone (3A4>2C8); rosiglitazone (2C8> 2C9).
- Limited number of potential drug-drug interactions observed with metformin.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
DEFINITION
- Certain antibiotics may produce undesired changes in glycemic control when used in persons with diabetes.
- No apparent interactions are described between antibiotics and insulins.
- Serum concentrations of hypoglycemic agents may change due to inhibition or induction of oxidative metabolism (i.e. cytochrome P450 system) including: meglitinides (repaglinide, nateglinide), sulfonylureas (glyburide, glimepiride, glipizide), and glitizones (pioglitazone, rosiglitazone).
- Specific cytochrome P450 substrates: repaglinide (2C8, 3A4); nateglinide (2C9>3A4); glyburide and glipizide (2C9); pioglitazone (3A4>2C8); rosiglitazone (2C8> 2C9).
- Limited number of potential drug-drug interactions observed with metformin.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 5, 2017
Citation
Auwaerter, Paul. "Antimicrobials With Special Precautions in Diabetes." Johns Hopkins Diabetes Guide, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547010/3.4/Antimicrobials_with_Special_Precautions_in_Diabetes.
Auwaerter P. Antimicrobials with Special Precautions in Diabetes. Johns Hopkins Diabetes Guide. 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547010/3.4/Antimicrobials_with_Special_Precautions_in_Diabetes. Accessed March 23, 2023.
Auwaerter, P. (2017). Antimicrobials with Special Precautions in Diabetes. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547010/3.4/Antimicrobials_with_Special_Precautions_in_Diabetes
Auwaerter P. Antimicrobials With Special Precautions in Diabetes [Internet]. In: Johns Hopkins Diabetes Guide. ; 2017. [cited 2023 March 23]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547010/3.4/Antimicrobials_with_Special_Precautions_in_Diabetes.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antimicrobials with Special Precautions in Diabetes
ID - 547010
A1 - Auwaerter,Paul,M.D.
Y1 - 2017/01/05/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547010/3.4/Antimicrobials_with_Special_Precautions_in_Diabetes
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
